ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
18.693,37
0,04%
S&P 500
5.304,72
0,70%
Dow Jones
39.069,59
0,01%
Euro vs US Dollar
1,08485
0,00%
Bitcoin
69.086,79
-0,26%
Registration Strip Icon for monitor Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ
  6. Immuron Ltd (IMRN)

  7. Immuron Ltd (IMRN) News

IMRN

Immuron (IMRN)

Immuron Ltd
Von:
Sortieren nach:
 Showing the most relevant articles for your search:NASDAQ:IMRN
DatumZeitQuelleÜberschriftSymbolFirma
03/05/202412h00GlobeNewswire Inc.Immuron Director ResignationNASDAQ:IMRNImmuron Ltd
15/04/202412h00GlobeNewswire Inc.Immuron to host Live Virtual EventNASDAQ:IMRNImmuron Ltd
10/04/202412h00GlobeNewswire Inc.Immuron Travelan® sales continued strong growthNASDAQ:IMRNImmuron Ltd
07/03/202414h00Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:IMRNImmuron Ltd
07/03/202412h00GlobeNewswire Inc.Immuron Announces Positive Results Support Travelan® progress to Phase 3 Clinical Trials in the USNASDAQ:IMRNImmuron Ltd
28/02/202414h08Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:IMRNImmuron Ltd
21/02/202414h00Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:IMRNImmuron Ltd
21/02/202412h00GlobeNewswire Inc.Immuron Presentation Australian Biologics Festival 2024NASDAQ:IMRNImmuron Ltd
13/02/202414h00Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:IMRNImmuron Ltd
13/02/202412h00GlobeNewswire Inc.Immuron achieves record Travelan® salesNASDAQ:IMRNImmuron Ltd
08/02/202412h00GlobeNewswire Inc.Immuron CEO, Steven Lydeamore Investor Webinar PresentationNASDAQ:IMRNImmuron Ltd
16/01/202414h00Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:IMRNImmuron Ltd
16/01/202412h00GlobeNewswire Inc.Immuron achieves record half yearly Travelan® salesNASDAQ:IMRNImmuron Ltd
22/12/202313h21Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:IMRNImmuron Ltd
22/12/202312h00GlobeNewswire Inc.Immuron Clinical Trials UpdateNASDAQ:IMRNImmuron Ltd
04/12/202312h32Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:IMRNImmuron Ltd
04/12/202312h00GlobeNewswire Inc.Immuron Announces First Patients Enrolled in Campylobacter Challenge Clinical StudyNASDAQ:IMRNImmuron Ltd
28/11/202312h33GlobeNewswire Inc.Immuron CEO, Steven Lydeamore Investor Webinar PresentationNASDAQ:IMRNImmuron Ltd
28/11/202312h17Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:IMRNImmuron Ltd
22/11/202313h16Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:IMRNImmuron Ltd
21/11/202312h05Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:IMRNImmuron Ltd
14/11/202300h00GlobeNewswire Inc.Immuron CEO Steven Lydeamore Investor Webinar PresentationNASDAQ:IMRNImmuron Ltd
13/11/202314h28Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:IMRNImmuron Ltd
30/10/202313h00Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:IMRNImmuron Ltd
30/10/202312h21GlobeNewswire Inc.Immuron CEO Steven Lydeamore presented at AusBioInvestNASDAQ:IMRNImmuron Ltd
23/10/202314h00Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:IMRNImmuron Ltd
18/10/202312h05Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:IMRNImmuron Ltd
18/10/202312h00GlobeNewswire Inc.Immuron Announces Travelan® Clinical Study Cohort 2 commencesNASDAQ:IMRNImmuron Ltd
11/10/202312h09Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:IMRNImmuron Ltd
11/10/202312h00GlobeNewswire Inc.Immuron achieves record quarterly Travelan® salesNASDAQ:IMRNImmuron Ltd
 Showing the most relevant articles for your search:NASDAQ:IMRN

Kürzlich von Ihnen besucht

COIN
UMAKRW
UMA Voting Token v1
NYSE
KRC
Kilroy Realty
TSXV
TAR
Astar Minerals Ltd.
AQSE
DAXX.GB
Amundi DAX III UCITS ETF...
BMF
WDOQ18
LSE
SG11
Sgissu_na_sg11
NASDAQ
NGHCO
National General
COIN
BXTGBP
TSXV
MUN
Mundoro Capital
HITB
SBTCBTC
Super Bitcoin
NYSE
HOO
BIT
P1PKE0
BNP Paribas Issuance
USOTC
OGSTS
Otis Gallery (GM)
BIT
UB4QA3
Unicredit Bank
UNSW3
THNETH
Throne
BIT
F05048
Vontobel Financial Produ...
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten